Biologic Contract Manufacturing WebinarPosted on May 28, 2024 |
 |
June 6, 2024, 10:00 a.m. – 12:00 p.m. EST
Michael Hausladen, PhD, General Manager,
LOTTE Biologics
Register in advance for this meeting here.
After registering, you will receive a confirmation email.
Michael Hausladen is the General Manager for LOTTE Biologics USA, LLC, headquartered in Syracuse, NY. LOTTE Biologics is a Contract Development and Manufacturing Organization that is serving the biologic pharmaceutical market. Previous roles at Bristol Myers Squibb (BMS) included starting up the Devens, MA $350M Cell Therapy Facility, managing clinical external biologics manufacturing and various leadership roles including Director of Manufacturing and Director of Manufacturing Technology.
Prior to working in biologics, Michael worked at BMS scaling up and commercialization of enzyme catalyzed and traditional organic synthesis of active pharmaceutical ingredients. Michael has a PhD in chemical engineering from the University at Buffalo.
Other Member News
February 27, 2026DisrUpstate Launches DisruptHER Commons to Support Women Leaders Across Central New YorkThe event reflects growing demand for accessible leadership support, community connection, and locally rooted professional development opportunities for women across Central New York’s evolving workforce. |
February 25, 2026Turning Stone Enterprises Warms Up Seasonal Hiring with 75 Full- and Part-Time Job Opportunities in Golf, Groundskeeping and at The Cove at Sylvan BeachCandidates are invited to explore more than 75 seasonal job opportunities at Turning Stone Enterprises’ Golf and Greens hiring event on Tuesday, March 3 and at a March 7 hiring event for The Cove at Sylvan Beach, Turning Stone Enterprises… |
